Literature DB >> 16796601

Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia.

N A C H Brabers1, H S L M Nottet.   

Abstract

Human immunodeficiency virus-1 (HIV-1)-infected and immune-activated macrophages and microglia secrete neurotoxins. Two of these neurotoxins are the pro-inflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta), which are thought to play a major role in inducing neuronal death. Both TNF-alpha and IL-1beta increase the permeability of the blood-brain barrier, through which subsequently HIV-infected monocytes can enter the brain. They both induce over-stimulation of the NMDA-receptor via several pathways, resulting in a lethal neuronal increase in Ca(2+) levels. Additionally, TNF-alpha co-operates with several other proinflammatory mediators to enhance their toxic effects. Although most research has focused on the neurotoxic effects of TNF-alpha and IL-1beta in HAD, there is also evidence that these cytokines can be neuroprotective. In this paper the effect of TNF-alpha and IL-1beta on neuronal life and death in HAD is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796601     DOI: 10.1111/j.1365-2362.2006.01657.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  123 in total

Review 1.  Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.

Authors:  Michael G Chez; Natalie Guido-Estrada
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil.

Authors:  Sergio Monteiro de Almeida; Francisco Jaime Barbosa; Rujvi Kamat; Ana Paula de Pereira; Sonia Mara Raboni; Indianara Rotta; Clea Elisa Ribeiro; Mariana Cherner; Ronald J Ellis; Joseph Hampton Atkinson
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

3.  Anti-inflammatory Function of Phyllostachys Edulis Extract in the Hippocampus of HIV-1 Transgenic Rats.

Authors:  Xiaosha Pang; Jun Panee
Journal:  J HIV AIDS       Date:  2016-05-11

4.  NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.

Authors:  Chao Zhang; Jin-Wen Song; Hui-Huang Huang; Xing Fan; Lei Huang; Jian-Ning Deng; Bo Tu; Kun Wang; Jing Li; Ming-Ju Zhou; Cui-Xian Yang; Qi-Wen Zhao; Tao Yang; Li-Feng Wang; Ji-Yuan Zhang; Ruo-Nan Xu; Yan-Mei Jiao; Ming Shi; Feng Shao; Rafick-Pierre Sékaly; Fu-Sheng Wang
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

5.  Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.

Authors:  Yongbo Yang; Jianguo Wu; Yuanan Lu
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

Review 6.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 7.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 8.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

9.  Interleukin-1 mediates long-term hippocampal dentate granule cell loss following postnatal viral infection.

Authors:  Anna G Orr; Anup Sharma; Nikolaus B Binder; Andrew H Miller; Bradley D Pearce
Journal:  J Mol Neurosci       Date:  2009-09-23       Impact factor: 3.444

Review 10.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.